NCT06381154 2026-01-30
Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer
Mayo Clinic
Phase 2 Recruiting
Clinical Trials
11 trialsNCT06807359 2025-12-18
Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System
SpectraCure AB
Phase 1/2 Recruiting
NCT06306638 2025-11-25
Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction
Roswell Park Cancer Institute
Phase 1/2 Recruiting
NCT03033225 2025-07-30
Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study
Mayo Clinic
Phase 2 Completed
NCT04590664 2025-02-25
Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma
Emory University
Phase 1/2 Recruiting
NCT03067051 2024-12-03
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
SpectraCure AB
Phase 1/2 Recruiting
NCT02702700 2019-03-20
PDT-lipo
Centre Hospitalier Universitaire Vaudois
Phase 1 Terminated
NCT02939274 2018-07-20
An Open Label, Phase II Trial of Continuous Low-Irradiance Photodynamic Therapy (CLIPT) Using Verteporfin (Visudyne®) for the Treatment of Cutaneous Metastases of Breast Cancer
Rogers Sciences Inc.
Phase 2 Unknown
NCT02872064 2018-04-06
Treatment of Primary Breast Cancer Using PDT
University College, London
Phase NA Completed
NCT00007969 2013-11-06
Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT00002647 2013-09-20
Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors
National Cancer Institute (NCI)
Phase 1 Unknown